SCHEMBL19009632

SCHEMBL19009632

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4cc(-c5ccc6cc7ccccc7cc6c5)ccc4c3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 2/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
CYP17A1 P05093 1/20 0.48
CYP19A1 P11511 1/20 0.48
ESR1 P03372 3/20 0.48
ESR2 Q92731 3/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HSD17B1 P14061 1/20 0.47
HSD17B2 P37059 1/20 0.47
CYP1A1 P04798 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932635 0.96 MEN1 (0.53) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL23633641 0.94 MEN1 (0.56) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL21446906 0.94 MEN1 (0.56) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL17655964 0.94 MEN1 (0.56) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL26154643 0.94 MEN1 (0.59) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL23633564 0.94 MEN1 (0.59) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL16716654 0.94 MEN1 (0.59) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL23633715 0.94 MEN1 (0.59) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL23633509 0.92 MEN1 (0.58) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL23633682 0.92 MEN1 (0.58) MEN1KMT2AALDH1A1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 MEN1 2816/4885KMT2A 1971/4885ALDH1A1 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.